n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone has been researched along with oxotremorine in 9 studies
Studies (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Trials (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Recent Studies (post-2010) (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Studies (oxotremorine) | Trials (oxotremorine) | Recent Studies (post-2010) (oxotremorine) |
---|---|---|---|---|---|
15 | 0 | 0 | 1,930 | 6 | 99 |
Protein | Taxonomy | n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone (IC50) | oxotremorine (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.4 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 5 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 2.321 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.7261 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.7261 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.7261 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 8 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.7261 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.5012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hyslop, DK; Sethy, VH | 1 |
Booth, RA; Jenden, DJ; Russell, RW; Smith, CA; Waite, JJ | 1 |
Booth, RA; Jenden, DJ; Overstreet, DH | 1 |
Francis, JW; Sethy, VH | 1 |
Ehlert, FJ | 1 |
Jenden, DJ; Ringdahl, B | 1 |
Ehlert, FJ; Jenden, DJ | 1 |
Booth, RA; Jenden, DJ; Overstreet, DH; Rice, KM; Russell, RW | 1 |
Dahlbom, R; Ehlert, FJ; Jenden, DJ; Resul, B; Ringdahl, B | 1 |
9 other study(ies) available for n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone and oxotremorine
Article | Year |
---|---|
Effect of irreversible loss of muscarinic receptors on (3H)-acetylcholine release from the hippocampus.
Topics: Acetylcholine; Animals; Hippocampus; Male; Oxotremorine; Parasympatholytics; Pyrrolidinones; Rats; Rats, Inbred Strains; Receptors, Muscarinic | 1990 |
Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Conditioning, Operant; Male; Motor Activity; Nociceptors; Oxotremorine; Parasympathomimetics; Pyrrolidinones; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic | 1986 |
Effects of an irreversible muscarinic agonist (BM123) on avoidance and spontaneous alternation performance.
Topics: Animals; Atropine; Atropine Derivatives; Avoidance Learning; Behavior, Animal; Body Temperature; Dose-Response Relationship, Drug; Male; Oxotremorine; Parasympatholytics; Pyrrolidinones; Rats; Rats, Inbred Strains; Receptors, Muscarinic | 1988 |
Regulation of brain acetylcholine concentration by muscarinic receptors.
Topics: Acetylcholine; Animals; Arecoline; Brain; Homeostasis; Male; Mice; Microwaves; Oxotremorine; Pyrrolidinones; Receptors, Muscarinic; Time Factors | 1988 |
Effects of an alkylating derivative of oxotremorine (BM 123A) on heart rate, muscarinic receptors and adenylate cyclase activity in the rabbit myocardium.
Topics: Adenylyl Cyclases; Animals; Aziridines; Azirines; Guanosine Triphosphate; Heart Rate; Male; Mathematics; Myocardium; N-Methylscopolamine; Oxotremorine; Pyrrolidinones; Rabbits; Receptors, Muscarinic; Scopolamine Derivatives | 1987 |
Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
Topics: Analgesics; Animals; Atropine; Body Temperature Regulation; Male; Mice; Oxotremorine; Parasympathomimetics; Pyrrolidinones; Salivation; Structure-Activity Relationship; Tremor | 1987 |
The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Topics: Alkylation; Animals; Atropine; Benzodiazepinones; Binding Sites; Binding, Competitive; Cerebral Cortex; Gallamine Triethiodide; Kinetics; N-Methylscopolamine; Oxotremorine; Pirenzepine; Pyrrolidinones; Quinuclidinyl Benzilate; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Structure-Activity Relationship; Thiosulfates | 1985 |
Unexpected synergism between an alkylating analog of oxotremorine and soman.
Topics: Acetylcholinesterase; Animals; Atropine; Atropine Derivatives; Body Temperature; Brain; Carboxylesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Drug Synergism; Oxotremorine; Parasympatholytics; Pyrrolidinones; Rats; Rats, Inbred Strains; Soman | 1985 |
The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
Topics: Alkylation; Animals; Aziridines; Azirines; Binding, Competitive; Carbachol; Chlorides; Guinea Pigs; Hydrolysis; Ileum; Indicators and Reagents; Kinetics; Muscle Contraction; Oxotremorine; Pyrrolidinones; Quinuclidinyl Benzilate; Rana pipiens; Receptors, Muscarinic | 1984 |